Vaxart is a gamble for biotechnology investors, with its upside too dependent on the approval of an oral vaccine. More
Articles
Latest Bad News Suggests Novavax Stock Might Be Cursed
Merck’s experimental oral Covid-19 antiviral drug is not good news for Novavax or NVAX stock. It might be time to reconsider your bet. More
PLTR Stock Is Soaring Today Thanks to This $823 Million Catalyst
Palantir is taking on another defense contract, and its been welcome news for PLTR stock, which has been soaring all morning. More
Even in a Volatile Market, You’ll Want to Buy SoFi Stock
SOFI stock could trade sideways (or lower) in the months ahead, but now may be time to enter a long-term position. More
4 Reasons to Ignore Seasonality and Seize AMD Stock
October has been a notoriously bad month for AMD stock investors, but this time may be different. If not, here's why you must buy the dip. More
XYO: Analyzing This Specialized Crypto for Geolocation
XYO is gaining popularity following its recent listing on Coinbase. But will its app catch on, or might privacy concerns trip it up? More
